Las enfermedades alérgicas suponen un coste directo de entre 1.800 y 6.600 euros por paciente al año
02 juin 2024 17h07 HE
|
European Academy of Allergy and Clinical Immunology
VALENCIA, España, June 02, 2024 (GLOBE NEWSWIRE) -- Las enfermedades alérgicas suponen un coste de entre 1.823 y 6.656 euros por paciente al año si solo tenemos en cuenta los gastos directos...
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
02 juin 2024 17h07 HE
|
European Academy of Allergy and Clinical Immunology
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
Arranca en Valencia el Congreso de la EAACI
31 mai 2024 13h11 HE
|
European Academy of Allergy and Clinical Immunology
VALENCIA, España, May 31, 2024 (GLOBE NEWSWIRE) -- Con el lema “Revolucionando la atención al paciente a través del poder de la ciencia de los datos”, ha comenzado el congreso internacional...
EAACI Congress Kicks Off in Valencia, Spain
31 mai 2024 13h11 HE
|
European Academy of Allergy and Clinical Immunology
EAACI Congress Kicks Off in Valencia, Spain
Precision Medicine, Immunotherapy, and Artificial Intelligence (AI) as Key Topics
Allergy Vaccine Market Trends, Forecast and Competitive Analysis: A $3.6 Billion Market by 2030 with a CAGR of 7.5% from 2024 to 2030
31 mai 2024 04h18 HE
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Allergy Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The global...
Presentación del Congreso de la Academia Europea de Alergología e Inmunología Clínica (EAACI) que se celebrará en Valencia del 31 de mayo al 3 de junio
30 mai 2024 09h37 HE
|
European Academy of Allergy and Clinical Immunology
VALENCIA, España, May 30, 2024 (GLOBE NEWSWIRE) -- Con el lema «Revolucionando la atención al paciente a través del poder de la ciencia de los datos», el congreso destacará el papel...
Presentation of the Congress of the European Academy of Allergy and Clinical Immunology (EAACI) to be held in Valencia from May 31 to June 3
30 mai 2024 09h37 HE
|
European Academy of Allergy and Clinical Immunology
We are delighted to invite you to the opening press conference of our EAACI Annual Congress 2024 in Valencia or online via the link below.
Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal
23 mai 2024 08h47 HE
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, May 23, 2024 (GLOBE NEWSWIRE) -- HAMILTON, BERMUDA – May 23, 2024 -- Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company dedicated to developing and...
Atopia Therapeutics, Formerly HpVac, Announces Appointment of Dr. Gregoire Chevalier as CEO and Business Update
07 mai 2024 04h09 HE
|
AKAMPION
Geneva (Switzerland), May 7, 2024 – Atopia Therapeutics, a leader in the development of breakthrough asthma and allergy therapies, today announced the appointment of Dr. Grégoire Chevalier as Chief...
2024 年欧洲过敏与临床免疫学会大会:过敏治疗的创新和进步
30 avr. 2024 02h58 HE
|
European Academy of Allergy and Clinical Immunology
大会期间将举行 150 多场科学会议,重点探讨环境科学、食物过敏、免疫疗法创新和儿科过敏等方面的进展。作为规模最大的过敏和免疫学盛会,本次大会将汇聚精准医学、人工智能、免疫疗法和免疫调节剂等前沿领域。大会将于 5 月 31 日至 6 月 3 日在西班牙巴伦西亚举行。 巴伦西亚,西班牙, April 30, 2024 (GLOBE NEWSWIRE) -- 由来自 125 个国家的...